Home NDC 0703-1501 Alprostadil
Product NDC 0703-1501
11-digit product format 007031501
Labeler code 0703
Product ID 0703-1501_85a64fab-2879-4a7b-9367-d6e7a8b5043e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Alprostadil
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVASCULAR
Labeler Teva Parenteral Medicines, Inc.
Application ANDA075196
Marketing category ANDA
Marketing start 1999-04-30
Marketing end 0000-00-00
Substance ALPROSTADIL
Active strength 500 ug/mL
Pharmacologic classes Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [CS],Venous Vasodilation [PE]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0703-1501-02 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0703-1501-02 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0703-1501-02 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0703-1501-02 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0703-1501-02 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0703-1501-02 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0703-1501-02 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0703-1501-02 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0703-1501-02 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0703-1501-02 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0703-1501-02 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0703-1501-02 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075196-001 ALPROSTADIL ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A075196-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A075196-001 ALPROSTADIL 0.5MG/ML INJECTABLE / INJECTION AP 1999-04-30 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Alprostadil ALPROSTADIL Meitheal Pharmaceuticals Inc. 35d229e1-6947-435c-bf54-bfa09cca7e53 2024-06-04 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 075196 application number: ANDA075196
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0703-1501-02 00703150102 5 VIAL, SINGLE-USE in 1 CARTON (0703-1501-02) > 1 mL in 1 VIAL, SINGLE-USE (0703-1501-01) 1999-04-30 0000-00-00 No No Current